<qa>  What is the primary objective of the vaccine?- Primary objective is to evaluate the safety of 3 different dosages 20μg - 50μg and 100μg of the PRIMVAC vaccine adjuvanted either with Alhydrogel or GLA-SE, and administered at D0, D28 and D56 in healthy European and Burkinabe adults. 